Evogene's Lavie Bio Subsidiary Announces Licensing Agreement For Bio-Fungicides With Corteva Agriscience; Agreement Grants Corteva Righs To Further Develop And Commercialize Bio-Fungicide Product Candidates
Portfolio Pulse from Benzinga Newsdesk
Evogene's subsidiary, Lavie Bio, has announced a licensing agreement for bio-fungicides with Corteva Agriscience. The agreement grants Corteva the rights to further develop and commercialize bio-fungicide product candidates.
July 17, 2023 | 11:33 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Corteva Agriscience has secured a licensing agreement with Lavie Bio, a subsidiary of Evogene. This could potentially expand Corteva's product portfolio and increase its market share in the bio-fungicide sector.
The licensing agreement allows Corteva Agriscience to develop and commercialize bio-fungicide product candidates. If successful, this could lead to an expanded product portfolio and increased market share for Corteva.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evogene's subsidiary, Lavie Bio, has entered into a licensing agreement with Corteva Agriscience. This could potentially increase Evogene's revenues if the bio-fungicide products are successfully commercialized.
The licensing agreement allows Corteva Agriscience to develop and commercialize bio-fungicide product candidates. If successful, this could lead to increased revenues for Evogene.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100